Split designed to achieve compliance with Nasdaq minimum bid price requirements BOSTON, May 2, 2025 /PRNewswire/ -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) ("TransCode" or the "Company"), the RNA Oncology Company™ committed to more effectively treating cancer using RNA therapeutics,...
Read More Details
Finally We wish PressBee provided you with enough information of ( TransCode Therapeutics Announces 1-for-28 Reverse Stock Split )
Also on site :
- Costco's Sturdy New Bookshelf Is So Stunning, Shoppers are Buying 2 at a Time
- Israel Recovers Bodies of Three Hostages Held by Hamas in Gaza
- Grammy-Winning Hitmaker Declines Fan's Luxe Gift, Offers Unforgettable Experience